Clinical Trials Directory

Trials / Unknown

UnknownNCT03842371

Metabolism of Branched-chain Amino Acids in Monocyte/Macrophage During Sepsis

Metabolism of Branched-chain Amino Acids in Monocyte and Macrophage During Sepsis

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
West China Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

The current project was designed to examine the metabolic level of branched-chain amino acids in plasm and monocyte/macrophage, and its role in immune dysfunction during sepsis.

Detailed description

In this study, the investigators will collect the peripheral blood of 1,3,7,14 day after diagnose of sepsis. Then, the concentration of branched-chain amino acids(BCAAs) in monocytes and plasma, and the expression of BCAAs metabolic enzymes in monocytes will be determined. Additionally, the inflammatory cytokines, e.g., Interleukin-1β (IL-1β), Tumor necrosis factor-α (TNF-α), Interleukin-10 (IL-10), the chemokines macrophage inflammatory proteins 1α and 1β (MIP-1α and 1β) in the peripheral blood and the phagocytic function of monocytes will also be detected. The current project was designed to examine the metabolic level of branched-chain amino acids in plasm and monocyte/macrophage, and its role in immune dysfunction during sepsis.

Conditions

Interventions

TypeNameDescription
OTHERMetabolic level of BCAAs in monocytes and macrophagesMetabolic level of BCAAs in monocytes and macrophages

Timeline

Start date
2019-02-11
Primary completion
2021-12-30
Completion
2022-02-28
First posted
2019-02-15
Last updated
2019-02-15

Source: ClinicalTrials.gov record NCT03842371. Inclusion in this directory is not an endorsement.